| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023587 |
| Receipt No. | R000027165 |
| Official scientific title of the study | The effects of amino acids mixture during exercise |
| Date of disclosure of the study information | 2016/08/19 |
| Last modified on | 2017/02/09 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The effects of amino acids mixture during exercise | |
| Title of the study (Brief title) | The effects of amino acids mixture during exercise | |
| Region |
|
|
| Condition | |||
| Condition | Healthy subjects | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To compare the effects of amino acid mixture with placebo during exercise. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Blood cortisol |
| Key secondary outcomes | Questionnaire
Blood glucose Blood ACTH Blood CK Blood lactate Blood NH3 Blood free fatty acid Blood total ketone bodies |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Exercise A after ingestion of test product-> Washout-> Exercise A after ingestion of control product-> Washout-> Exercise B after ingestion of test product
Washout-> Exercise B after ingestion of control product |
|
| Interventions/Control_2 | Exercise A after ingestion of control product-> Washout-> Exercise B after ingestion of control product-> Washout-> Exercise A after ingestion of test product
Washout-> Exercise B after ingestion of test product |
|
| Interventions/Control_3 | Exercise B after ingestion of test product-> Washout-> Exercise A after ingestion of test product-> Washout-> Exercise B after ingestion of control product-> Washout-> Exercise A after ingestion of control product | |
| Interventions/Control_4 | Exercise B after ingestion of control product-> Washout-> Exercise B after ingestion of test product-> Washout-> Exercise A after ingestion of control product
Washout-> Exercise A after ingestion of test product |
|
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1)Subjects who have given written informed consent
2)Healthy males aged 20 to 39 years old 3)Subjects whose BMI ranges from 18.5 to 25.0 4)Subjects whose blood cortisol increased during exercise at screening |
|||
| Key exclusion criteria | 1)Subjects with food allergies
2) Subjects having a smoking habit 3) Subjects who had blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study 4)Subjects who are currently participating in other clinical studies 5)Subjects who are judged as ineligible by the doctor for other reasons |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Katsuhisa Sakano |
| Organization | CPCC Company Limited |
| Division name | Clinical Reserch Planning Department |
| Address | 4F Chushin Build. 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047 Japan |
| TEL | 03-5297-3112 |
| k.s@cpcc.co.jp | |
| Public contact | |
| Name of contact person | Makoto Ichinohe |
| Organization | CPCC Company Limited |
| Division name | Plan Sales Department |
| Address | 4F Chushin Build. 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047 Japan |
| TEL | 03-5297-3112 |
| Homepage URL | |
| m.i@cpcc.co.jp | |
| Sponsor | |
| Institute | CPCC Company Limited |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Meiji Co., Ltd |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | チヨダパラメディカルケアクリニック(東京都)/Chiyoda Paramedical Care Clinic(Tokyo) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000027165 |